Literature DB >> 8899295

Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis.

P Beauparlant1, J Hiscott.   

Abstract

The NF-kappa B/Rel family of transcription factors participates in the activation of a diverse range of genes involved in inflammation, immune response, lymphoid differentiation, growth control and development. The present review provides a brief overview of NF-kappa B/Rel activation and a detailed analysis of important biological and biochemical inhibitors of the NF-kappa B/Rel pathway. Given the pleiotropic role of NF-kappa B in controlling cytokines and other immunoregulatory genes, the inhibition of NF-kappa B activation by steroid hormones, antioxidants, protease inhibitors and other compounds may provide a pharmacological basis for interfering with pathological inflammatory conditions, cancer and AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899295     DOI: 10.1016/1359-6101(96)00020-2

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  24 in total

1.  Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers.

Authors:  Alla V Tsytsykova; Ricardo Rajsbaum; James V Falvo; Filipa Ligeiro; Simon R Neely; Anne E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

2.  Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.

Authors:  R Lin; C Heylbroeck; P M Pitha; J Hiscott
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1.

Authors:  L Minghetti; A Nicolini; E Polazzi; A Greco; M Perretti; L Parente; G Levi
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 4.  Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation.

Authors:  S M McHugh; T L Rowland
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

5.  Suppression of lung inflammation in rats by prevention of NF-kappaB activation in the liver.

Authors:  L H Lancaster; J W Christman; T R Blackwell; M A Koay; T S Blackwell
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

6.  Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation.

Authors:  P Schwenger; D Alpert; E Y Skolnik; J Vilcek
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats.

Authors:  Rajesh Aneja; Paul W Hake; Timothy J Burroughs; Alvin G Denenberg; Hector R Wong; Basilia Zingarelli
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

8.  Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.

Authors:  Jeremy O Jones; Ann M Arvin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors.

Authors:  C Jobin; C Hellerbrand; L L Licato; D A Brenner; R B Sartor
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

10.  Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein.

Authors:  F Besançon; A Atfi; C Gespach; Y E Cayre; M F Bourgeade
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.